A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors

Clinical trial NCT00722293 · COMPLETED

Trial details

NCT number: NCT00722293
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasms, Breast

Start date: 2008-07-08
Primary completion: 2012-06-11
Enrollment: 111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.